Ekso Bionics to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024

Rhea-AI Summary

Ekso Bionics Holdings, Inc. (EKSO) will release financial and business results for Q4 and full year 2023 on March 4, 2024. The Company, known for exoskeleton technology, will host a conference call to discuss the results and recent developments.

SAN RAFAEL, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the fourth quarter and full year 2023 after the close of trading on Monday, March 4, 2024. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.

A live webcast of the event will be available in the “Investors” section of the Company’s website at www.eksobionics.com, or by clicking here. Investors interested in listening to the conference call may do so by dialing 877-407-3036 for domestic callers or 201-378-4919 for international callers.

A webcast replay will also be available on the Company’s website for one month following the completion of the call.

About Ekso Bionics^® 
Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Founded in 2005, the Company continues to build upon its industry-leading expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only known exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol “EKSO.”

Investor Contact:
David Carey
212-867-1768
investors@eksobionics.com

 

FAQ

When will Ekso Bionics release financial and business results for Q4 and full year 2023?

Ekso Bionics will release financial and business results for the fourth quarter and full year 2023 after the close of trading on Monday, March 4, 2024.

What time will the conference call to discuss financial results and recent business developments begin?

The conference call to discuss the financial results and recent business developments will begin at 1:30 p.m. PT / 4:30 p.m. ET.

How can investors access the live webcast of the event?

Investors can access the live webcast of the event in the 'Investors' section of Ekso Bionics' website at www.eksobionics.com or by clicking on the provided link.

What are the dial-in numbers for domestic and international callers to listen to the conference call?

Domestic callers can dial 877-407-3036, while international callers can dial 201-378-4919 to listen to the conference call.

How long will the webcast replay be available on Ekso Bionics' website?

The webcast replay will be available on the Company's website for one month following the completion of the call.